Literature DB >> 2502471

Production of pneumolysin, a pneumococcal toxin, in Bacillus subtilis.

S Taira1, E Jalonen, J C Paton, M Sarvas, K Runeberg-Nyman.   

Abstract

We have expressed the pneumolysin gene of Streptococcus pneumoniae in Bacillus subtilis, both from its own promoter and as a fusion protein. The level of expression of pneumolysin from its own promoter was low. The protein produced was hemolytically active. A higher level of expression (about 10 micrograms/ml of culture) was achieved when either one of two C-terminal fragments (corresponding to amino acids 265-471 and 55-471, respectively) or the entire coding part of the pneumolysin gene were fused to the promoter and signal sequence-coding region of the alpha-amylase gene of Bacillus amyloliquefaciens. The C-terminal fusion peptides reacted with anti-pneumolysin serum, but were not hemolytically active. In both cases most of the peptide remained cell-associated. When the entire pneumolysin gene was fused to the signal sequence, a hemolytically active form of pneumolysin could be detected, and most of the product was found in a processed form in the culture supernatant. The full-length pneumolysin secreted from B. subtilis was partially purified and used as antigen in an enzyme immunoassay with rabbit anti-pneumolysin serum.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2502471     DOI: 10.1016/0378-1119(89)90069-3

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  10 in total

1.  Viridans group streptococci are donors in horizontal transfer of topoisomerase IV genes to Streptococcus pneumoniae.

Authors:  Luz Balsalobre; María José Ferrándiz; Josefina Liñares; Fe Tubau; Adela G de la Campa
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

Review 2.  Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Spain: update (1990 to 1996).

Authors:  A Fenoll; I Jado; D Vicioso; A Pérez; J Casal
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

3.  Validation of immune-complex enzyme immunoassays for diagnosis of pneumococcal pneumonia among adults in Kenya.

Authors:  J A Scott; A J Hall; M Leinonen
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

4.  Characterization of a recombinant pneumolysin and its use as a protein carrier for pneumococcal type 18C conjugate vaccines.

Authors:  J Kuo; M Douglas; H K Ree; A A Lindberg
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

Review 5.  Protein secretion in Bacillus species.

Authors:  M Simonen; I Palva
Journal:  Microbiol Rev       Date:  1993-03

6.  Development and characterization of a subtilin-regulated expression system in Bacillus subtilis: strict control of gene expression by addition of subtilin.

Authors:  Roger S Bongers; Jan-Willem Veening; Maarten Van Wieringen; Oscar P Kuipers; Michiel Kleerebezem
Journal:  Appl Environ Microbiol       Date:  2005-12       Impact factor: 4.792

7.  Horizontal transfer of parC and gyrA in fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae.

Authors:  M J Ferrándiz; A Fenoll; J Liñares; A G De La Campa
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

8.  Characterization of LytA-like N-acetylmuramoyl-L-alanine amidases from two new Streptococcus mitis bacteriophages provides insights into the properties of the major pneumococcal autolysin.

Authors:  Patricia Romero; Rubens López; Ernesto García
Journal:  J Bacteriol       Date:  2004-12       Impact factor: 3.490

9.  Nasopharyngeal antibodies to pneumococcal pneumolysin in children with acute otitis media.

Authors:  A Virolainen; J Jero; H Käyhty; P Karma; J Eskola; M Leinonen
Journal:  Clin Diagn Lab Immunol       Date:  1995-11

10.  Mapping of immunoreactive sites of pneumococcal pneumolysin by use of synthetic peptides.

Authors:  P Salo; A Närvänen; M Leinonen
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.